Prime Medicine (PRME) Other Non-Current Assets (2021 - 2025)
Historic Other Non-Current Assets for Prime Medicine (PRME) over the last 5 years, with Q3 2025 value amounting to $13.7 million.
- Prime Medicine's Other Non-Current Assets fell 263.83% to $13.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.7 million, marking a year-over-year decrease of 263.83%. This contributed to the annual value of $14.1 million for FY2024, which is 419.38% up from last year.
- Prime Medicine's Other Non-Current Assets amounted to $13.7 million in Q3 2025, which was down 263.83% from $13.7 million recorded in Q2 2025.
- In the past 5 years, Prime Medicine's Other Non-Current Assets ranged from a high of $14.1 million in Q3 2024 and a low of $13.1 million during Q4 2021
- Over the past 5 years, Prime Medicine's median Other Non-Current Assets value was $13.5 million (recorded in 2022), while the average stood at $13.6 million.
- Its Other Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 419.38% in 2024, then crashed by 263.83% in 2025.
- Quarter analysis of 5 years shows Prime Medicine's Other Non-Current Assets stood at $13.1 million in 2021, then grew by 2.83% to $13.5 million in 2022, then changed by 0.0% to $13.5 million in 2023, then rose by 4.19% to $14.1 million in 2024, then decreased by 2.64% to $13.7 million in 2025.
- Its Other Non-Current Assets was $13.7 million in Q3 2025, compared to $13.7 million in Q2 2025 and $14.1 million in Q1 2025.